Clin2
NCT07322835Possibly a fitNot yet recruiting

Restoring blood flow for mild strokes in China

Minor Ischemic Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial compares different ways to restore blood flow in people who have had a mild ischemic stroke. Doctors want to see which treatment approach is safest and most effective for improving recovery, using clot-busting medicine and/or a clot-removal procedure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,400 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years of age or older.
  • Before this stroke, you were able to do all your usual daily activities without help (no significant disability).
  • You have had an ischemic stroke (a blockage in a blood vessel in the brain) that was confirmed by a CT or MRI scan.
  • Your stroke started (or you were last seen well) no more than 24 hours before you arrive at the hospital.
  • Your stroke symptoms are mild (score of 5 or less on a standard stroke scale).
  • You are willing to receive standard stroke treatment, which may include clot-busting medicine and/or a procedure to remove the clot, depending on your situation.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07137832Recruiting· Phase 3
Testing clot-busting drug during stroke treatment for medium vessel blockages

This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.

Guangzhou, Guangdong
NCT07476898Not yet recruiting· Phase 3
Reperfusion therapy for disabling minor stroke with large vessel blockage

This trial tests a precise treatment to restore blood flow in people who had a mild but disabling stroke up to 24 hours earlier, using mechanical clot removal or clot-busting medication. The goal is to reduce long-term disability by reopening the blocked vessel while protecting healthy brain tissue.

Fuzhou, Fujian
NCT06155032Recruiting
Clot Removal for Worsening Mild Stroke

This trial tests whether emergency clot removal (endovascular therapy) can help people whose mild stroke gets worse within a week. It's for those who have a blockage in a large brain artery and enough healthy brain tissue to save.

Fuyang, Anhui
NCT07115940Recruiting
Clot removal after 24 hours for stroke patients

This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.

Chicago, Illinois
NCT06115070Not yet recruiting· Phase 4
Clot-busting drug for mild stroke symptoms

This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.

Hangzhou
NCT07598799Not yet recruiting
Arm blood-flow pauses after clot removal for stroke recovery

This trial tests a simple procedure that may help your brain recover after a stroke. The procedure involves briefly stopping and restarting blood flow in your arm, which may reduce brain damage and improve recovery after the clot removal.

Hear when a new Minor Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.